Current through Register Vol. 24, December 22, 2023
(1) Prescriptions
[or drug orders] shall include, but not be limited to:
(a) patient's name;
(b) name of drug, device, or
biological;
(c) strength of drug or
biological, if applicable;
(d)
dosage form of drug or biological, if applicable;
(e) quantity of drug, device, or biological
prescribed;
(f) directions for
use;
(g) date of
issuance;
(h) prescriber's name;
(i) if the prescription is written, it must
contain the prescriber's hand-written signature and the name of the prescriber
stamped, typed, printed, or clearly handwritten in addition to the
signature;
(ii) if the prescription
is written, it must be tamper-resistant and contain all of the following
characteristics:
(A) one or more
industry-recognized features designed to prevent unauthorized copying of a
completed or blank prescription form;
(B) one or more industry-recognized features
designed to prevent the erasure or modification of information written on the
prescription pad by the prescriber; and
(C) one or more industry-recognized features
designed to prevent the use of counterfeit prescription forms.
(i) number of refills
authorized;
(i) when the refill designation
on the prescription is prn or Pro re nata, such designation, unless otherwise
limited, means a refill for one year;
(ii) if a prescription is for a controlled
substance in Schedules III, IV, or V, refill five times in the six months from
the date of issuance;
(iii) if a
prescription is for a noncontrolled drug, device, or biological, refill for 12
months from the date of issuance;
(iv) controlled substances in Schedule II
cannot be refilled and a refill designation for a controlled substance in
Schedule II has no meaning.
(j) if the prescription is for a controlled
substance, the following additional information is required to be on the
prescription:
(i) patient's address;
(ii) prescriber's address; and
(iii) prescriber's Drug Enforcement
Administration (DEA) registration number.
(2) Prescription or refill authorization
issued by a prescriber may be communicated to a pharmacist or a pharmacist
intern by an employee or agent of the prescriber.
(3) "Brand name medically necessary" shall be
handwritten (or printed if electronically generated) on the face of the
prescription if it is medically necessary that an equivalent drug product not
be selected.
(4) "Chart order"
means a lawful order entered on the chart or a medical record of an inpatient
or resident of an institutional facility by a practitioner, or his or her
designated agent, for a drug or device and shall be considered a
prescription.
Renumbered
from 24.174.510 to
24.174.831,
2015
MAR p. 303, Eff.
3/27/2015
